0000899243-19-022285.txt : 20190822 0000899243-19-022285.hdr.sgml : 20190822 20190822161519 ACCESSION NUMBER: 0000899243-19-022285 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190820 FILED AS OF DATE: 20190822 DATE AS OF CHANGE: 20190822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ATWOOD BRIAN G CENTRAL INDEX KEY: 0001266567 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35347 FILM NUMBER: 191046251 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clovis Oncology, Inc. CENTRAL INDEX KEY: 0001466301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900475355 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 625-5000 MAIL ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-20 0 0001466301 Clovis Oncology, Inc. CLVS 0001266567 ATWOOD BRIAN G C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY, SUITE 100 BOULDER CO 80301 1 0 0 0 Common Stock 2019-08-20 4 M 0 25862 0.29 A 25862 D Common Stock 25577 I By Atwood-Edminster Trust dated 4/2/2000 Common Stock 101217 I By Versant Venture Capital IV, L.P. Common Stock 638 I By Versant Side Fund IV, L.P. Stock Option (right to buy) 0.29 2019-08-20 4 M 0 25862 0.00 D 2019-08-26 Common Stock 25862 0 D The Reporting Person is is a trustee and a named beneficiary of the Atwood-Edminster Trust dated 4/2/2000. The Reporting Person is a managing member of Versant Ventures IV, LLC. Voting and investment power over the shares held of record by Versant Venture Capital IV, L.P. and Versant Side Fund IV, L.P is held by Versant Ventures IV, LLC, their sole general partner. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and the options held by him. The option was immediately exercisable as to both vested and unvested shares. 25% of the shares subject to the option vested on each of August 26, 2009, August 26, 2010, August 26, 2011 and August 26, 2012. /s/ Brian G. Atwood 2019-08-22